Atea Pharmaceuticals, Inc.
NASDAQ:AVIR
3.35 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||||||||||||
| Net Income
| -40.522 | -63.169 | -39.164 | -33.142 | -28.183 | -35.467 | -34.431 | -8.066 | -31.335 | -42.077 | 117.132 | -28.194 | 1.539 | 30.713 | 20.656 | -17.622 | -9.993 | -3.988 | -4.655 | -3.632 | -3.554 | -2.193 |
| Depreciation & Amortization
| 0.104 | 0.104 | 0.104 | 0.104 | 0.104 | 0.104 | 0.104 | 0.106 | 0.043 | 0.007 | 0.007 | 0.007 | 0.008 | 0.007 | 0.006 | 0.005 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.005 |
| Deferred Income Tax
| 0 | 0 | -8.508 | -37.459 | -31.88 | 0 | 0 | 0 | 0 | 0 | 247.845 | 0 | 0 | 0 | -300.205 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 12.72 | 12.586 | 12.157 | 12.383 | 12.353 | 12.535 | 11.645 | 11.504 | 11.908 | 11.661 | 11.351 | 10.99 | 10.007 | 7.273 | 2.821 | 4.238 | 0.209 | 0.189 | 0.174 | 0.157 | 0.147 | 0.146 |
| Change In Working Capital
| -11.48 | 14.102 | 9.414 | 7.381 | 3.303 | -3.935 | 4.137 | -22.321 | 0.214 | -28.616 | -203.913 | 39.8 | -28.902 | -54.83 | 295.038 | 3.898 | 1.982 | -0.713 | 0.549 | -0.208 | 1.122 | -1.211 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 4.514 | -4.514 | 0 | 0 | 0 | 50 | -50 | 0 | -5.815 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 533.494 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Accounts Payables
| -15.667 | 16.885 | 3.857 | -3.567 | 3.262 | -1.851 | 1.433 | -12.767 | 10.228 | -0.877 | -17.656 | 11.489 | 12.724 | 3.732 | -4.177 | 1.046 | 2.793 | -0.15 | 0.447 | -0.617 | 0 | 0 |
| Other Working Capital
| 4.187 | -2.783 | 5.557 | 10.948 | 0.041 | -2.084 | -1.81 | -5.04 | -10.014 | -27.739 | -186.257 | 28.311 | -41.626 | -58.562 | -228.464 | 2.852 | -0.811 | -0.563 | 0.102 | 0.409 | 1.122 | -1.211 |
| Other Non Cash Items
| 25.571 | -7.579 | 4.163 | 33.142 | 28.183 | -3.087 | -3 | -15.232 | -0.016 | 0.016 | -247.845 | -0.485 | -2.701 | 3.555 | 300.205 | 1.046 | 2.793 | -0.15 | 0.447 | -0.617 | 0.389 | -0.062 |
| Operating Cash Flow
| -42.202 | -39.865 | -21.834 | -17.591 | -16.12 | -29.85 | -21.545 | -21.242 | -19.186 | -59.009 | -75.423 | 22.603 | -17.348 | -16.837 | 318.521 | -9.481 | -7.798 | -4.508 | -3.928 | -3.679 | -1.892 | -3.315 |
| Investing Activities: | ||||||||||||||||||||||
| Investments In Property Plant And Equipment
| 0 | 0 | 0 | 0 | 0 | 0 | 1.943 | -0.02 | -1.879 | -0.044 | -0.004 | 0 | 0 | 0 | -0.005 | -0.015 | -0.006 | 0 | 0 | -0.002 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -7.264 | -167.196 | -47.23 | -205.288 | -153.218 | -156.626 | -58.397 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 131.95 | 223.998 | 75.001 | 146.775 | 199.783 | 181.106 | 91.885 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 124.686 | 56.802 | 0.028 | -0.059 | 0.047 | 0.024 | -1.943 | -486.955 | 0 | 0 | -0.004 | 0 | 0 | 0 | -0.026 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| 124.686 | 56.802 | 27.771 | -58.513 | 46.565 | 24.48 | 33.488 | -486.975 | -1.879 | -0.044 | -0.004 | 0 | 0 | 0 | -0.005 | -0.015 | -0.006 | 0 | 0 | -0.002 | 0 | 0 |
| Financing Activities: | ||||||||||||||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 0.15 | 0 | 0.092 | 0 | 0.165 | 0.23 | 0 | 0 | 0.223 | 1.465 | 0.795 | 0.057 | 0.471 | 214.116 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0 | 0.15 | 0 | 0 | 0 | 0 | -0.23 | 0.147 | 0 | 0.223 | -1.323 | 0.795 | 0.057 | 0.471 | 212.102 | -0.913 | 106.449 | -0.006 | 0 | 0 | 0 | 0 |
| Financing Cash Flow
| 0 | 0.15 | 0 | 0.092 | 0 | 0.165 | 0 | 0.147 | 0 | 0.223 | 0.142 | 0.795 | 0.057 | 0.471 | 426.218 | -0.913 | 106.449 | -0.006 | -0.015 | 0 | 0 | 0 |
| Other Information: | ||||||||||||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 42.87 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 82.484 | 17.087 | 5.937 | -76.012 | 30.445 | -5.205 | 11.943 | -508.07 | -21.065 | -58.83 | -75.285 | 23.398 | -17.291 | -16.366 | 744.734 | -10.409 | 98.645 | -4.514 | -3.943 | -3.681 | -1.892 | -3.315 |
| Cash At End Of Period
| 243.394 | 160.91 | 143.823 | 137.886 | 213.898 | 183.453 | 188.658 | 176.715 | 684.785 | 705.85 | 764.68 | 839.965 | 816.567 | 833.858 | 850.224 | 105.49 | 115.899 | 17.254 | 21.768 | 25.711 | 29.392 | 31.284 |